Increased GFAP plasma levels have been associated with neurological disability, defined as intracranial hemorrhage, brain infarction, cerebral edema, or brain death, in children receiving extracorporeal membrane oxygenation [14] and with abnormal functional outcomes in neonates with birth asphyxia and born preterm [26]. This evidence concerns the gene GFAP and intracranial hemorrhage.